Literature DB >> 9109056

A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs.

J A Cordero1, L Alarcon, E Escribano, R Obach, J Domenech.   

Abstract

The transdermal absorption of a series of nonsteroidal antiinflammatory drugs (NSAIDs): indomethacin, ketoprofen, diclofenac, piroxicam, tenoxicam, ketorolac, and aceclofenac) was studied in vitro with human skin. The purpose of the study was to determine the permeation parameters (permeability rate constant, Kp; lag time, TL, and flux, J) as measures of the intrinsic transdermal permeabilities of these drugs to predict their potential for formulation in a transdermal therapeutic system (TTS). A linear correlation was established between the intrinsic log Kp values and the intrinsic partition coefficients (r = 0.863, p = 0.012, n = 7). Diclofenac had the highest value of in vitro transdermal penetration at approximately 0% ionization (Kp = 3.5 cm/h) and ketoprofen had the highest flux (J = 16 micrograms/h.cm2) of the NSAIDs assayed. Ketorolac would provide the plasma concentrations at steady state that would be nearest to the therapeutic concentration (Cr/Css = 26). Also, considering the whole permeation profile in vitro, ketorolac would be the most suitable candidate of the series studied to be formulated as a TTS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9109056     DOI: 10.1021/js950346l

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  20 in total

1.  Heat and mass transfer scale-up issues during freeze-drying, III: control and characterization of dryer differences via operational qualification tests.

Authors:  S Rambhatla; S Tchessalov; Michael J Pikal
Journal:  AAPS PharmSciTech       Date:  2006-04-21       Impact factor: 3.246

2.  Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride.

Authors:  Mikolaj Milewski; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2010-06-25       Impact factor: 4.200

3.  Estimating Maximal In Vitro Skin Permeation Flux from Studies Using Non-sink Receptor Phase Conditions.

Authors:  Shereen Yousef; Xin Liu; Ahmed Mostafa; Yousuf Mohammed; Jeffrey E Grice; Yuri G Anissimov; Wedad Sakran; Michael S Roberts
Journal:  Pharm Res       Date:  2016-06-16       Impact factor: 4.200

4.  The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.

Authors:  Yasuhiro Tsume; Deanna M Mudie; Peter Langguth; Greg E Amidon; Gordon L Amidon
Journal:  Eur J Pharm Sci       Date:  2014-01-28       Impact factor: 4.384

5.  A fast and reliable spectroscopic method for the determination of membrane--water partition coefficients of organic compounds.

Authors:  B de Castro; P Gameiro; J L Lima; C Matos; S Reis
Journal:  Lipids       Date:  2001-01       Impact factor: 1.880

6.  Percutaneous delivery of thalidomide and its N-alkyl analogs.

Authors:  Colleen Goosen; Timothy J Laing; Jeanetta du Plessis; Theunis C Goosen; Guang-Wei Lu; Gordon L Flynn
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

7.  Developing Transdermal Applications of Ketorolac Tromethamine Entrapped in Stimuli Sensitive Block Copolymer Hydrogels.

Authors:  Mireia Mallandrich; Francisco Fernández-Campos; Beatriz Clares; Lyda Halbaut; Cristina Alonso; Luisa Coderch; Maria L Garduño-Ramírez; Berenice Andrade; Alfonso Del Pozo; Majella E Lane; Ana C Calpena
Journal:  Pharm Res       Date:  2017-05-24       Impact factor: 4.200

Review 8.  Oral versus topical NSAIDs in rheumatic diseases: a comparison.

Authors:  C A Heyneman; C Lawless-Liday; G C Wall
Journal:  Drugs       Date:  2000-09       Impact factor: 9.546

9.  Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs.

Authors:  Jelena Djordjevic; Bozena Michniak; Kathryn E Uhrich
Journal:  AAPS PharmSci       Date:  2003-10-16

10.  Comparison of Skin Permeation and Putative Anti-Inflammatory Activity of Commercially Available Topical Products Containing Ibuprofen and Diclofenac.

Authors:  Julie Pradal
Journal:  J Pain Res       Date:  2020-11-04       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.